The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 493.00
Bid: 490.00
Ask: 491.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.204%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 493.00
VSVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

27 Nov 2012 07:00

RNS Number : 0497S
Cookson Group PLC
27 November 2012
 



 

27 November 2012

Appointment of Finance Director of Alent plc

 

Cookson Group plc ("Cookson") announced on 1 November 2012 that the Performance Materials division is to be demerged to form a new London listed specialty chemicals company, Alent plc ("Alent"). These proposals were approved by the Court Meeting and the General Meeting of Cookson Shareholders on 26 November 2012 and the demerger is expected to become effective on 19 December 2012.

 

Cookson announces today that David Egan will become Finance Director of Alent with effect from 1 January 2013. 

 

Mr Egan is currently the Chief Financial Officer at ESAB, which was the largest division of Charter International plc which was itself acquired by Colfax Corporation in 2012.

 

Prior to joining ESAB in 2008, Mr Egan was Group Financial Controller of Hanson plc based in London, and prior to that Chief Financial Officer, Hanson Asia Pacific based in Singapore. He has extensive international experience of businesses in Europe, including the Russian Federation, Asia, Australasia, and the Americas.

 

Mr Egan is a qualified Certified Practicing Accountant (CPA), Australia and is a dual British and Australian citizen.

 

Peter Hill, Chairman designate of Alent, said:

 

"I look forward to welcoming David, with his wealth of experience in senior and international finance roles, to Alent's board. His appointment completes the line-up of what I believe will be a strong and experienced Board, with the depth and mix of skills to maximise the opportunities for Alent and its shareholders, as a stand-alone company."

 

As previously announced, Mike Butterworth, currently Group Finance Director of Cookson, will act as Interim Finance Director for Alent from listing until 1 January 2013.

 

No disclosure obligations arise under paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority's Listing Rules in respect of this appointment.

 

Ends

 

For further information please contact:

 

Shareholder/Analyst Enquiries:

 

Steve Corbett, Chief Executive designate, Alent plc

Mike Butterworth, Interim Finance Director, Alent plc

 

+44 (0)20 7822 0064

Frances Gibbons, Investor Relations Manager, Alent plc

 

+44 (0) 7850 880868

fgibbons@cookson.com

 

Media Enquiries:

 

John Olsen/Ian Payne

MHP Communications

 

+44 (0)20 3128 8100

 

 

About Alent plc:

 

Alent will comprise what is currently the Performance Materials division of Cookson, a leading global supplier of advanced surface treatment plating chemicals and electronics assembly materials.

 

Alent's principal end-market is global electronics production, accounting for approximately three quarters of revenue, with the other quarter represented by the automotive and other industrial markets.

 

Alent will be organised into two business segments:

 

·; Assembly Materials, trading as Alpha and supplying electronic interconnect materials to assemblers of printed circuit boards (PCBs) and the semiconductor packaging industry

 

·; Surface Chemistries, trading as Enthone and supplying specialty electroplating chemicals and services for use in semiconductors and PCB fabrication, as well as corrosion resistant/decorative coatings for various industries, particularly the automotive industry.

 

Alent had net sales value of £418 million and an adjusted trading profit of £96 million in the year ended 31 December 2011. The net sales value was split broadly one third in each of Europe, Asia and the Americas.

 

Alent is present in over 100 countries and has over 2,500 employees and 23 manufacturing sites worldwide. This enables Alent to supply its customers with highly engineered and customised specialty chemicals and materials on a just in time basis from its strategic locations around the world.

 

Alent's Board will comprise:

 

Peter Hill CBE Non-Executive Chairman

Steve Corbett Chief Executive

David Egan Finance Director

Dr Emma FitzGerald Non-Executive

Lars Förberg Non-Executive

Noël Harwerth Non-Executive; Chairman of the Remuneration Committee

Jan Oosterveld Non-Executive

Mark Williamson Non-Executive; Senior Independent Director; Chairman of Audit Committee

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVQLFLLFFLFBX
Date   Source Headline
1st Apr 20165:50 pmRNSHolding(s) in Company
4th Mar 20165:48 pmRNSHolding(s) in Company
3rd Mar 20167:00 amRNSFinal Results
10th Feb 20161:35 pmRNSHolding(s) in Company
29th Jan 201612:35 pmRNSTotal Voting Rights
19th Jan 201611:26 amRNSHolding(s) in Company
5th Jan 201611:32 amRNSHolding(s) in Company
29th Dec 20159:40 amRNSHolding(s) in Company
30th Nov 20154:43 pmRNSHolding(s) in Company
26th Nov 20159:49 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSTrading Update
9th Oct 20159:55 amRNSHolding(s) in Company
25th Sep 20154:03 pmRNSHolding(s) in Company
17th Sep 20157:00 amRNSDirectorate Change
15th Sep 201512:30 pmRNSHolding(s) in Company
25th Aug 20154:30 pmRNSHolding(s) in Company
24th Aug 201510:30 amRNSHolding(s) in Company
12th Aug 20153:00 pmRNSHolding(s) in Company
11th Aug 20153:00 pmRNSHolding(s) in Company
31st Jul 20157:00 amRNSHalf Yearly Report
30th Jun 20154:30 pmRNSTotal Voting Rights
30th Jun 201510:55 amRNSHolding(s) in Company
18th Jun 20154:00 pmRNSCapital Markets Event
17th Jun 20152:34 pmRNSHolding(s) in Company
10th Jun 20159:30 amRNSDirector Declaration
22nd May 20151:30 pmRNSDirector/PDMR Shareholding
14th May 20152:00 pmRNSResult of AGM
14th May 20157:00 amRNSAGM Trading Update
8th Apr 20154:45 pmRNSDirector/PDMR Shareholding
7th Apr 20155:15 pmRNSAnnual Financial Report
1st Apr 20154:43 pmRNSDirector/PDMR Shareholding
19th Mar 20154:28 pmRNSHolding(s) in Company
3rd Mar 20157:00 amRNSDirectorate Change
3rd Mar 20157:00 amRNSFinal Results
19th Feb 20152:02 pmRNSSettlement with MacDermid, Inc
9th Feb 201512:45 pmRNSHolding(s) in Company
30th Jan 20152:02 pmRNSTotal Voting Rights
20th Jan 20153:06 pmRNSHolding(s) in Company
1st Dec 20144:15 pmRNSHolding(s) in Company
1st Dec 20148:49 amRNSRejection of Vesuvius Proposal
1st Dec 20147:00 amRNSStatement of intention not to make an offer
24th Oct 20147:00 amRNSInterim Management Statement
20th Oct 20146:02 pmRNSDirector/PDMR Shareholding
16th Oct 20143:58 pmRNSHolding(s) in Company
30th Sep 201411:12 amRNSDirector/PDMR Shareholding
18th Aug 20147:00 amRNSTechnical services acquisitions in Brazil and USA
1st Aug 20147:00 amRNSHalf Yearly Report
24th Jul 201412:49 pmRNSHolding(s) in Company
30th Jun 20144:07 pmRNSBlocklisting Interim Review
30th Jun 20144:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.